E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Add to balance / Manage account  User:  Log out
Prospect News home > News index > List of issuers G > Headlines for GlycoGenesys Inc. > News item
Published on 2/7/2006 in the Prospect News Biotech Daily.

GlycoGenesys to be delisted from Nasdaq

By Ted A. Knutson

Washington, Feb. 7 - GlycoGenesys, Inc. said it received a letter from the Nasdaq Listing Qualifications Panel informing the company that its stock will be delisted from the Nasdaq Capital Market effective as of the open of business on Wednesday.

The disclosure was made in an 8-K filing with the Securities and Exchange Commission.

GlycoGenesys, a Boston-based biotechnology company, filed for Chapter 11 late last week.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.